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13C and 15N natural isotope 
abundance reflects breast cancer 
cell metabolism
Illa Tea1,2, Estelle Martineau1,3, Ingrid Antheaume1, Julie Lalande1, Caroline Mauve4, 
Francoise Gilard4, Sophie Barillé-Nion5, Anneke C. Blackburn2 & Guillaume Tcherkez6
Breast cancer is the most common cancer in women worldwide. Despite the information provided 
by anatomopathological assessment and molecular markers (such as receptor expression ER, PR, 
HER2), breast cancer therapies and prognostics depend on the metabolic properties of tumor cells. 
However, metabolomics have not provided a robust and congruent biomarker yet, likely because 
individual metabolite contents are insufficient to encapsulate all of the alterations in metabolic 
fluxes. Here, we took advantage of natural 13C and 15N isotope abundance to show there are isotopic 
differences between healthy and cancer biopsy tissues or between healthy and malignant cultured 
cell lines. Isotope mass balance further suggests that these differences are mostly related to lipid 
metabolism, anaplerosis and urea cycle, three pathways known to be impacted in malignant cells. Our 
results demonstrate that the isotope signature is a good descriptor of metabolism since it integrates 
modifications in C partitioning and N excretion altogether. Our present study is thus a starting point to 
possible clinical applications such as patient screening and biopsy characterization in every cancer that 
is associated with metabolic changes.
Medical applications of stable isotopes are now widespread, like the well-known 13C-urea breath assay for ulcer 
detection1. This takes advantage of 13C-labelling and thus usually neglects differences in reaction rates between 
isotopic forms, because the isotopic signal used for diagnosing is far above small natural variations in 13C. By 
contrast, the use of isotopes at natural abundance exploits such subtle differences (referred to as isotope effects) to 
identify bottlenecks in metabolic pathways (rate-limiting steps) or the contribution of multiple elemental sources 
(mass balance), without the need to introduce expensive isotope tracers into the patient. Isotope effects in metab-
olism are mostly caused by enzymatic reactions that preferentially consume substrates containing either the light 
or the heavy isotope (isotopologues) and therefore, the natural isotope abundance in metabolites depends on 
metabolic fluxes and source substrates2. For example, the natural 13C abundance in respired CO2 has been used 
to trace diet composition and substrate changes during exercise3,4. In cancer biology, the use of natural variations 
in Cu and S stable isotopes in hepatocellular carcinoma has been attempted recently5. But to our knowledge, no 
study has looked at alterations of natural isotope abundance in breast cancer. Due to changes in primary C and N 
metabolism such as increased glycolysis, glutaminolysis and nucleotide synthesis6, important changes in 13C and 
15N natural abundance can be anticipated.
To address this question, we examined the isotopic signature of intact breast cancer biopsies (mostly from 
invasive ductal carcinoma, IDC) and cultured breast cancer cell lines (Supplementary Tables S1 and S2) using ele-
mental analysis coupled to isotope ratio mass spectrometry (EA-IRMS). This technique has been recently shown 
to be applicable to the biochemical analysis of cancerous cell lines7.
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Results
Isotope signature of breast cancer biopsies. Natural 13C and 15N abundance was found to discriminate 
normal and cancerous biopsies, the latter being significantly 13C-enriched by ~4‰ and tended to be (though 
not significantly) 15N-depleted (Fig. 1a,b). Triple negative tissues (ER- PR- HER2-) tended to be relatively 
15N-depleted (Fig. 1a and Supplementary Table S1). The observed isotopic difference between cancerous and 
non-cancerous tissues can have been caused by either variation in chemical composition or isotope fractionations 
in metabolism.
First, there were alterations in total lipid content, which correlated to the 13C-abundance (Fig. 1c and 
Supplementary Figure S1). In fact, lipids are typically 13C-depleted components of human tissues8 and a systematic 
13C-depletion has been observed in adipose tissue9. Here, cancerous tissues are on average less lipid-rich, reflect-
ing the lower abundance of adipose cells in breast IDC10,11. Cancerous tissues were also enriched in nitrogenous 
compounds, as shown by the higher N elemental content (Fig. 1d). This effect is due to either a lower cellular N 
turnover rate or a higher content in protein and total amino acids including arginine (Supplementary Figure S2). 
Second, metabolic fluxes were modified thereby modifying the net exchange with the extracellular fluid and 
thus the overall (apparent) cellular isotope fractionation (see below). It is highly unlikely that the isotopic dif-
ference between biopsies was due to a confounding effect of nutritional preferences amongst patients (such as 
the proportion of animal proteins or sugars from C4-plants)12–14 because the comparison of paired normal and 
cancerous biopsy samples from the same patient still shows a significant difference for 13C (Fig. 1b). 13C and 15N 
abundance were also corrected so as to express them relative to a common elemental source (see Methods below). 
Moreover, female patients from which biopsies originated had the same geographical origin (western France) 
and thus important differences between nutritional habits or general isotope composition of body matter are 
improbable15.
Figure 1. Breast cancer biopsies are naturally 13C-enriched and nitrogen-rich. (a) The natural abundance 
in 13C (δ 13C, vs. V-PDB) and 15N (δ 15N, vs. air N2) differentiates control from tumor patient tissue samples 
(n = 23). One sample pair of healthy (adjacent) and cancerous tissues not characterized for receptors (u and u’, 
respectively) and three triple negative tumor samples (t) are also shown. (b) Taken as a whole, the change in the 
13C-abundance (Δ δ ) in cancerous tissues in tumor/adjacent tissue pairs was significant (P < 0.01, n = 5).  
(c) 13C-abundance (Δ δ ) was inversely correlated with the total lipid content (r2 = 0.48, P < 0.03). (d) Regardless 
of receptor expression, cancerous tissues had a higher elemental content in N (P < 0.05). In (a,c), each datum is 
the average of 3 sub-samples. In (d), lower case letters stand for statistical classes, P < 0.05.
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Metabolic alterations in breast cancer biopsies. Targeted metabolomics analyses by GC-MS were 
then carried out to identify major metabolic alterations. Normal tissues were clearly differentiated from cancer-
ous tissues in both unsupervised (PCA) and supervised (orthogonal partial least square-discriminant analysis, 
OPLS-DA) analysis (Supplementary Figures S3 and S4), with ethanolamine, methionine and arginine having 
the highest weight in such a differentiation (Supplementary Figures S3 and S4). Other discriminating metab-
olites included carbohydrates (such as fructose) and putrescine, and these metabolites have also been found to 
be significant elsewhere16,17. While the effect on free ethanolamine reflected the general reorchestration of lipid 
metabolism18, the simultaneous effect on arginine and putrescine strongly suggests perturbations in arginine 
metabolism (urea cycle), thereby causing changes in N excretion and thus, by mass balance, in 15N-abundance 
and N elemental content.
Isotopic signature of cell lines. Potentially, the isotopic signature in biopsies may have been influenced 
by non-controlled epidemiological and clinical factors (e.g., patient age, pharmacological treatments, etc.). 
Therefore, we also examined different cell lines cultured under isotopically-controlled conditions: one immortal-
ized, non-cancerous cell line (MCF10A) and six breast cancer cell lines (ZR75-1, MCF7, SKBR3, MDA-MB-231, 
MDA-MB-468 and Cal51, see Supplementary Table S2). The use of cultured cells further allowed us to carry out 
isotopic compound-specific analyses as well as targeted gene-expression, metabolomics and EA-IRMS analyses 
(see Methods) on the same samples.
With the exception of ZR75-1 (non-pleural origin, ER+ ), all other breast cancer cell lines were 15N-depleted 
(Fig. 2a). The 15N-abundance in DNA, proteins and total soluble metabolites paralleled that in total organic matter 
(Supplementary Figure S5). The 13C-abundance in non-cancerous cells was found to be lower than in cancerous 
cells (Fig. 2a). It did not correlate to the lipid content but rather to the 13C-abundance in lipids and loosely, to the 
content in C4 organic acids (Fig. 2b) which are known to be 13C-enriched19.
Primary metabolism in cell lines. The endometabolome (i.e., intracellular metabolome) was analyzed to 
gain information on primary C and N metabolism (summarized in Supplementary Figure S6a). Some metabolites 
such as arginine, urea and glucose were significantly different between cancer and normal cell lines. Close correla-
tions or anti-correlations were obtained between 13C- or 15N-abundance and key metabolites or metabolic ratios 
such as urea/arginine and fumarate/aspartate (Fig. 3a). As such, cancer cell lines could be differentiated from the 
MCF10A non-cancerous cells using these ratios (Fig. 3a).
The present results on both metabolome and isotopes suggest that three metabolic pathways are at the origin 
of the isotopic differences between cell lines: the urea cycle (arginine metabolism), the anaplerotic carbon fixa-
tion, and lipid synthesis. Transcript levels of a selection of genes encoding key enzymes of these pathways was 
examined by qPCR and in most cases, these genes were less expressed in cancer cell lines (Fig. 2c). Thus, rather 
than substantial changes in enzyme abundance, the alteration of isotope abundance was caused by changes in 
metabolic fluxes and/or net exchange of metabolites (absorption, excretion and accumulation) with the extracel-
lular medium.
Isotopic efflux in cell lines. We then examined the metabolic composition of the extracellular medium 
(exometabolome, Supplementary Figure S6b) to determine the preferential distribution (extracellular vs. intra-
cellular) of metabolites and compute isotopic fluxes (isofluxes). The extracellular-to-intracellular difference and 
Figure 2. Cancerous cell lines are naturally 13C-enriched and 15N-depleted. When compared to source C 
and N used for growth, the natural isotopic enrichment (ε 13C and ε 15N) differentiates the control immortalized 
line (MCF10A) and the breast tumor ascites-derived line (ZR75-1) from other adenocarcinoma lines (a). 
The isotope enrichment in lipids parallels that in total organic matter, and cancerous lines contain more 
(13C-enriched) C4-acids (b). Despite some variations, transcript quantitation of key enzymes shows a generally 
lower expression in cancer cells compared to MCF10A cells of enzymes of the urea cycle, lipid synthesis or the 
anaplerotic pathway (gene abbreviations in Supplementary Table S5), suggesting that metabolite excretion in 
addition to biosynthesis is involved in the isotopic differences (c).
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the 15N-abundance were found to be best anti-correlated with arginine, β -alanine, ethanolamine and spermidine 
(Supplementary Figure S6c,d). Amongst these, arginine had the highest value of the extracellular-to-intracellular 
difference (Fig. 3b,c) and was the most significantly different between cancer and normal cell lines (P < 0.005) 
and thus, appeared to be the best candidate to explain the 15N-depletion (Fig. 3d). There was little difference in 
the 15N-abundance of arginine itself amongst cell lines, although the non-cancerous (MCF10A) and ER lines 
(ZR75-1 and MCF7) synthesized 15N-enriched arginine (by a few ‰). Still, in all cases, arginine was much more 
15N-depleted than the isotopic influx (isotope composition of substrates consumed by cells from supplied culture 
medium) or extracellular urea (Fig. 3d). As a result, arginine efflux from cells represented a very substantial part 
of the isotopic efflux to the extracellular medium in both ZR75-1 and MCF10A lines but was modest in others 
(Fig. 3e). That is, cancerous lines were naturally 15N-depleted (Fig. 3b) because of the proportionally lower excre-
tion of 15N-depleted arginine. The higher metabolic ratio urea-to-arginine then comes as no surprise: it reflected 
the prevalence of arginine metabolism via the urea cycle (Fig. 3a).
Discussion
We showed isotopic differences between healthy and cancer tissues or cells, and provided evidence that these 
differences are related to urea, anaplerotic C fixation and/or lipid metabolism, and that the balance in nitrogen 
metabolism is modified in breast adenocarcinoma tissues or cells compared to normal breast tissues or cells 
thereby altering the natural 15N-abundance (Fig. 4). The consumption of glutamine (glutaminolysis) is a major 
pathway in cancerous cells20 that involves deamidation by glutaminase, thereby producing ammonia which is 
partly recycled and excreted in the form of urea. Here, source glutamine is naturally 15N-depleted (δ 15N = − 6.5‰) 
and 14N/15N isotope effects in both deamidation and the urea cycle21–23 yield 15N-depleted arginine. The efflux 
(excretion) of arginine does not counterbalance the N influx and this imbalance is compensated for by intracel-
lular build-up and recycling into polyamines and β -alanine (Fig. 4) thereby causing a general 15N-depletion of 
organic matter. In addition to acid metabolism (C4-acids and lactate, Fig. 2b, Supplementary Table S3), the urea 
cycle incorporates bicarbonate (naturally 13C-enriched)24 via the action of carbamoyl phosphate synthase and 
thus, arginine build-up contributes to the enrichment of 13C in cells. This appears indeed to be the best expla-
nation considering known isotope effects in metabolism6,21,25–29 (Supplementary Table S4). In fact, the natural 
13C-enrichment cannot come from a change in total lipid content (as in tumors) since lipid content variation was 
small (Supplementary Figure S7) and furthermore, the isotope composition in lipids followed that in total organic 
matter (Fig. 2b).
Quite noticeably, the isotopic pattern seen in tumor biopsies was similar to that found in cell lines, that is, with 
a tendency to be 15N-depleted and 13C-enriched (Fig. 1a). This pattern is unlikely to come from an effect of nutri-
tion, but rather explained by the specific primary C and N metabolism in tumor tissues, as explained above (Fig. 1). 
The metabolic origin of the 13C-enrichment was different to that in cultured cells (a decrease in total lipid content 
in tumors, Supplementary Figure S7 and refs 18,30). This is not surprising since cultured cell metabolism is dif-
ferent from that of cells in situ. By contrast, the mechanism explaining the lower 15N-abundance was similar: a net 
influx of 15N-depleted nitrogen associated with any metabolism. In cancerous cultured cells, there is an increased 
activity of the urea cycle and non-quantitative excretion of 15N-depleted arginine. In tumors in situ, it is believed 
Figure 3. Cancerous cell lines excrete less 15N-depleted arginine (Arg). The role of Arg metabolism (urea 
cycle) is further demonstrated by the differences in ratios of endometabolites since Arg appears to be more 
retained relative to urea in cancerous cell lines (a). The extracellular-to-intracellular relative difference (D) in 
Arg was found to (i) be the best D value that anti-correlates to δ 15N (b) and (ii) have the largest average D value 
across cell lines (c). In all cases, the δ 15N value of the influx (substrate consumption) was close to 0‰ while the 
efflux (excreted N) was 15N-depleted and Arg was even more 15N-depleted in cancerous cell lines by up to ≈ 7‰  
(d). Therefore, the relative isotopic efflux represented by Arg excretion (i.e., the quotient of Arg isoefflux to total 
isoefflux) was large in ZR75-1 and MCF10A and low in other cell lines (e). Asterisks: significant differences 
between cell lines (*P < 0.05; **P < 0.01); dashed line: δ 15N of source Gln (d); lower case letters stand for 
statistical classes (P < 0.05) (e). EA, ethanolamine, 2HG, 2-hydroxyglutarate; PGA, phosphoglycerate; PHB, 
parahydroxybenzoate.
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that cells are arginine-dependent to sustain polyamine metabolism31, and the auxotrophy of tumors for arginine 
has been exploited in the development of anticancer therapies32. Therefore cells capture naturally 15N-depleted 
arginine from their microenvironment, thereby leading to a 15N-depletion of cellular organic matter. Such a 
mechanism agrees with the well-known increase in polyamine metabolism33 and the fact that urea and glutamine 
(glutaminase activity) are amongst the best urinary and tumor biomarkers for breast cancer, respectively34,35. 
Also, differential expression of arginase, a key enzyme of the urea cycle, has been reported in breast cancer cell 
lines36,37.
The natural abundance in 13C and 15N thus reflects primary metabolism of cancer cells and thus, offers potential 
opportunities for development of biomarkers for clinical research. Consistently, healthy and cancerous samples 
were found to fall in corresponding regions of the isotopic landscape (Fig. 1a), and normal and cancerous cell lines 
could be differentiated (Fig. 2a). The ability of natural 13C- or 15N-abundance to further differentiate tumor grade 
and severity remains to be explored. In addition, there is a potential use the natural isotope abundance to distin-
guish between different breast cancer subtypes, as they have been shown to have different metabolic phenotypes38. 
Also, isotopic measurements would be best adapted to clinical settings if measured in plasma metabolites rather 
than in biopsies and thus, future work on both the accuracy and applicability of such plasma isotopic markers is 
required. For example, 15N natural abundance in plasma arginine could be exploited as a marker provided the 
metabolic activity of the tumor has a detectable effect on the total circulating arginine pool. That isotopic sig-
nature of tumorous breast tissues is due to alterations in major pathways of primary metabolism highlights the 
potential relevance of our findings to other cancer types which also display changes in metabolic fluxes.
Methods
Human Tissues. Fresh human mammary samples were obtained from chemotherapy naive patients with 
invasive carcinoma after surgical resection at the Institut de Cancérologie de l’Ouest – René Gauducheau, Nantes, 
France. Informed consent was obtained from patients to use their surgical specimens and clinicopathological data 
for research purposes, as required by the French Committee for the Protection of Human Subjects (CCPPRB). 
Ouest IV – Nantes CCPPRB approved use of tumor tissues for this study (6 May 2013: no. 357/2013). The collec-
tion of tumors was approved by the French Minister of higher education and research (no. AC-2008-141). This 
study did not require additional ethical approval. Amongst 17 breast cancer patients, 12 breast cancer samples 
and 5 pairs of breast cancer and adjacent non-cancerous tissues were obtained. One normal breast sample was 
obtained from reduction mammoplasty. For tumors, hormonal receptors, histological type and grade information 
were available, except that a paired of tissue #22/#19 (Supplementary Table S1, u and u’ in Fig. 1a) did not have 
receptor status available.
Cultured cells. Six human breast cancer cell lines and one non-cancerous cell line (Supplementary Table S2) 
were used and grown as monolayer cultures (107 cells/75  m2 flask). The cancer cells were grown in no-glucose 
Figure 4. Major metabolic pathways are responsible for changes in the natural 13C and 15N abundance in 
cancerous cultured cells. Glutamine (Gln) is a major N and C source from which N is removed via hydrolysis 
(glutaminase ➊) and the urea cycle (➋). These reactions are both fractionating against 15N thereby yielding 
15N-depleted urea and arginine (Arg). Therefore, build-up and recycling rather than excretion of Arg (dotted 
arrow) tend to deplete cancer cells of 15N. Cells are also 13C-enriched due to the fixation of bicarbonate by 
carbamoyl-phosphate (CP) synthesis (to feed the urea cycle ➌) and the anaplerotic pathway (➍), as well as a 
lower 13C content in non-structural lipids (dotted arrow). Lipids that are 13C-depleted come from the natural 
13C-depletion in acetyl-CoA (Ac-CoA) (inherited from naturally 13C-depleted C-atom positions in glucose) 
and the isotope effect of pyruvate dehydrogenase45,46 (➎). Amine acceptors are denoted as ‘A’ and oxaloacetate 
(OAA) converted to aspartate (Asp) is provided as an example. 2OG, 2-oxoglutarate; Pyr, pyruvate; Lact, lactate. 
The potential contribution of respiration (CO2 loss) and lactate excretion to the natural 13C-abundance is 
described in Supplementary Table S4.
www.nature.com/scientificreports/
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no-glutamine DMEM supplemented with 10% FBS and 1% 10,000 units/ml penicillin, 10,000 units/ml strep-
tomycin at 37 °C in a humidified atmosphere of 5% CO2. The non-cancerous cell line (MCF10A) was grown in 
DMEM/F-12 (no-glucose no-glutamine) supplemented with 5% horse serum, 0.01% EGF (Epidermal Growth 
Factor), 0.005% cholera toxin, 0.1% insulin, 0.005% hydrocortisone, and 1% HEPES. L-glutamine and D-glucose 
(4 and 25 mM, respectively) were added separately to culture mediums to ensure these nutrients were isotopically 
identical for all cells. The same cells were grown several times to test the biological variability. As soon as cells 
were confluent (~107 cells), cell counting and extraction were done using triplicate cell culture flasks. One flask 
was used for cell counting, after harvesting with trypsin, using trypan blue staining and microscopic hemocy-
tometry. For other analyses carried out on the other flasks, cells were then prepared as an aqueous (isotopes) or 
methanolic (metabolomics) extract without using trypsin as explained below.
Extraction and separation of studied fractions. Human tissues. Human fresh tissues were lyoph-
ilised. Lipids were extracted from the dried human tissues (10 mg) with hexane (1 mL). After centrifugation 
(4000 rpm, 15 min, 4 °C), the pellet was kept for metabolomics and the lipids were recovered by evaporation of 
hexane under a stream of N2 gas at 40 °C.
Cultured cells. After culture, cells were washed twice with PBS, and 3 mL of cold water was added to the flask. 
Cells were detached from the flask using a cell scraper. The lysed cell preparation was kept at − 20 °C for 48 h 
and then lyophilized. Different fractions (lipids, total soluble fraction (TSF), protein and DNA) were extracted 
and separated from the dry cell material. To obtain a lipid fraction, lyophilized cells (40 mg) were ground and 
extracted twice under agitation with 2 mL cyclohexane for 5 min at 20 °C. After centrifugation (4000 rpm, 5 min, 
20 °C), the lipid fraction (4 mL of cyclohexane) was dried under a stream of N2 gas at 40 °C and the dry residue 
stored at − 20 °C until required. To obtain a total soluble fraction, the pellet (insoluble in cyclohexane) obtained 
after centrifugation were ground and extracted twice with 2 mL methanol/water (80:20 v/v) for 5 min at 20 °C. 
After centrifugation (4000 rpm, 5 min, 20 °C), the total soluble fraction was dried under a stream of N2 gas at 
40 °C and the dry residue stored at − 20 °C until required. The pellet (insoluble in methanol/water) consisted of 
a protein fraction.
For DNA purification, lyophilised cells (15 mg) were reconstituted with 1 mL water and extracted with an 
equal volume of phenol/chloroform in an ultrasound bath for 30 min. After centrifugation (4000 rpm, 5 min, 
4 °C), the aqueous phase was filtered to remove proteins and the DNA was precipitated with an equal volume of 
isopropanol (1 mL). After gentle agitation, the DNA fragments were pelleted by centrifugation (4000 rpm, 5 min, 
4 °C), washed twice with ethanol (70%) to remove impurities, and dried under a stream of N2 gas at 40 °C.
13C and 15N abundance by elemental-analysis coupled to isotope ratio mass spectrometry 
(EA-IRMS). Subcellular fractions (see above) were lyophilized for EA-IRMS analysis, in order to detect their 
13C and 15N isotopes. From each sample ~0.7 mg was weighed with 10−5 g precision balance (Ohaus Discovery 
DV215CD, Pine Brook, New Jersey, USA) into each of three tin capsules (solids “light” 5 × 9 mm, Thermo Fisher 
Scientific, www.thermo.com) for isotope analysis. EA-IRMS analyses were performed as previously described7. 
The 13C and 15N abundance was first expressed as δ values (δ 13C and δ 15N, in ‰) as δ = R/Rst − 1 where R is the 
heavy-to-light isotope ratio and Rst stands for the isotope ratio in the international reference (V-PDB for 13C and 
air N2 for 15N).
The isotope abundance in sample fractions was expressed relative to that in total organic matter using the 
enrichment (in ‰) ε = δ f − δ tom where δ f is the δ value in the fraction of interest (lipids, proteins, etc.) and δ tom 
the (non-corrected) δ value in total organic matter. The enrichment ε is then positive if the sample fraction is 
enriched in the heavy isotope and negative if it is depleted. In this way, ε nearly equals the opposite of the isotope 
fractionation Δ (which is given by [δ tom − δ f]/[δ f + 1] ≈ δ tom − δ f). For total organic matter in Figs 1 and 2 and 
Supplementary Figure S3, δ values were corrected to allow comparisons between patients (that may have had 
different nutritional preferences) and between cell lines (that had slightly different culture media), as follows:
In cultured cells, it was corrected for the δ value of the elemental C and N source using the classical relation-
ships accounting for isotope fractionation: δ corr = (δ av − Δ )/(Δ + 1) where Δ = (δ srce − δ )/(δ + 1), δ srce is the δ value 
of the elemental source and δ av is δ value used as the reference (here, the average of δ srce values was used as the ref-
erence value; note that any change in this value would not change the pattern seen here, it would only change the 
absolute scale of δ corr values). δ srce was the δ 15N and δ 13C of source amino acids and sugars, respectively, in intact 
culture medium. When expressed as a fractionation (Fig. 2a), the isotope composition in total organic matter of 
cells is given as ε = δ − δ srce. That way, ε values are positive when it is enriched in the heavy isotope and negative 
when it is depleted, as for ε in individual cell fractions (see above).
For biopsies, δ srce could not, quite obviously, be known because food composition of patients was not con-
trolled. We therefore had to use a correction that could be calculated independently of food composition. The 
major influence of nutrition on elemental composition and isotopes is the protein/fat ratio of ingested food39, 
with fat-rich and protein-poor food causing a general increase in %C (and decrease in %N) and a general decrease 
in both δ 15N and δ 13C in body tissues. Therefore, we renormalized the δ values in total organic matter by taking 
into account the %C and %N using δ corr = δ + (1 − f )τ where f is the elemental composition relative to the average 
and τ is the apparent isotope fractionation between the whole population δ value (average isotope composition of 
human tissues in European western (French) population (δ a), − 22‰ and 9‰ for 13C and 15N, respectively) and 
the average of our samples (δ m): τ = δ a − δ m. For example, in this way, protein-rich samples (lean patients) that are 
naturally impoverished in elemental C and richer in 13C will have a negative correction for δ 13C. Of course, such a 
correction was not ideal because the knowledge of the average isotope composition of ingested food would have 
been better. In practice, this correction was minimal (on average, 0.02‰ for 13C and 0.5‰ for 15N) and did not 
cause a substantial bias in our data.
www.nature.com/scientificreports/
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15N-abundance and amino acid content using gas chromatography - combustion - isotope ratio 
mass spectrometry (GC-C-IRMS). When cells were confluent, the culture medium was kept (10 mL from 
~108 cells), and cells (~108) were washed with PBS and then lysed in 36 mL of 80% methanol. After homogeni-
zation, methanolic extracts were dried under a stream of N2 gas at 40 °C. Amino acids were prepared as their 
N-pivaloyl, O-isopropyl esters for GC-C-IRMS analysis, and used for both quantification (μ mol) and 15N values 
(‰) as previously described40.
13C-abundance in metabolites using liquid chromatography coupled to chemical oxidation and 
isotope ratio mass spectrometry (LC-co-IRMS). For LC-co-IRMS analysis, ~107 cells were used in 
12 mL of 80% methanol. LC-co-IRMS analysis was performed as previously described, using water as a mobile 
phase and a RS Pak KC-811 column (Shodex)41. δ 13C values were corrected using pure standard solutions at dif-
ferent concentrations. In practice, such corrections due to non-linearity were very small, about 0.2‰.
GC-MS metabolomics. Human biopsies. If material remained after lyophilization and lipid extraction, 
an additional ~10–15 mg of tissue was ground and dissolved in a standard solution of DL-2-Aminobutyric acid 
(0.2 mM, 950 μ L) and methanol/water (950 μ L, 80:20 v/v) was added to extract the soluble metabolites. After 
centrifugation (14000 rpm, 15 min, 4 °C), the soluble fraction was mixed with standard solution of ribitol (2 mM, 
95 μ L). The solution was centrifuged again and three aliquots of 200 μ L were dried using a speed-vac before deri-
vatization and GC-MS analysis as described previously41,42.
Cultured cells and extracellular medium. About 5 × 107 cells were dissolved in a solution of methanol/water 
(7 mL, 60:40 v/v) containing 500 μ L of a standard solution D,L-2-aminobutyric acid (0.2 mM). After centrifugation 
(14000 rpm, 15 min, 4 °C), the soluble fraction was mixed with another standard solution of ribitol (2 mM, 50 μL). 
The solution was centrifuged again and three aliquots of 1.4 mL, i.e. 20% of ~5 × 107 cells, were dried using a 
speed-vac before derivatization and GC-MS analysis. For extracellular medium, the same standard solutions [D,L-
2-aminobutyric acid (0.2 mM, 500 μ L) and ribitol (2 mM, 50 μ L) and methanol/water solution (500 μ L, 60:40 v/v)] 
were added to 500 μ L of media collected from the cultured cells. After a centrifugation, three aliquots of 300 μ L 
were prepared for GC-MS analysis. All metabolomics data were normalized to the specific number of cells so that 
the exo- and endo-metabolome could be directly compared.
RT-qPCR. RNA was isolated from cell lines and 500 ng RNA was reverse transcribed as previously described43. 
Quantitative PCR was done using the Maxima SYBR Green/ROX qPCR Master Mix (Life Technologies) and the 
MX4000 instrument (Stratagene, Basel, Switzerland), according to the manufacturer’s instructions. The endoge-
nous housekeeping genes RPLPO, HPRT1 and ACTB1 were used for normalization. Relative quantification was 
carried out by using the Δ Δ Ct method. Primer sequences are listed in Supplementary Table S5.
Statistics. Pair-wise comparisons were carried out using Student-Welsh tests, with a p-threshold value of 0.01 
unless otherwise stated in text. Metabolomics were examined using unsupervised analysis with principal compo-
nent analysis (PCA) or supervised analysis with orthogonal partial least square discriminant analysis (OPLS-DA), 
both carried out with Simca (Umetrics). Heat maps and hierarchical clustering (HCL) were done using the open 
source software MeV44. The HCL was carried out using the cosine correlation as a measure of proximity.
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